Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 12848
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
70896
Update out
stocker11
11/18/2021 8:38:53 AM
70895
Innovation Pharmaceuticals Provides Brilacidin
(4)
bettingbig
11/18/2021 8:38:01 AM
70892
"...Florida teacher hospitalized with COVID-19
(2)
farrell
11/16/2021 2:07:28 PM
70891
No way to know that all analysis has been
(5)
bandg
11/16/2021 11:04:31 AM
70890
The CRO is doing/has completed all the data
(3)
petemantx
11/16/2021 10:53:53 AM
70889
Heparin interacts with the main protease of
Boneysteak
11/16/2021 6:23:50 AM
70888
While most of us view them as the elephant in the
(8)
DrTim
11/15/2021 7:45:18 PM
70886
LOL - That's about PAR for the course. Don't know
NotRichYet2
11/15/2021 11:21:58 AM
70885
He's a Big Pharma insider who will continue
(2)
Drano
11/15/2021 11:07:27 AM
70884
Biden nominated Dr. Robert Califf, Cardiologist,
petemantx
11/15/2021 10:52:06 AM
70882
I agree in that Covid was an unexpected bonus to
(7)
petemantx
11/14/2021 4:50:47 PM
70881
Very well said. I think we got to go back and
(1)
Zadie
11/14/2021 7:40:02 AM
70880
Conclusion is wrong, IMO. Covid itself shut most
(1)
bandg
11/14/2021 6:56:33 AM
70877
The idea of using Brilacidin against COVID was a
(10)
Drano
11/13/2021 9:33:33 PM
70876
I am still hopeful that Compassionate Use (CU)
(10)
Mo
11/13/2021 7:05:03 PM
Newer
Older
Recent Articles
ASP Isotopes Faces Scrutiny After Controversial Report
Wall Street Is Spot On About 2024 Earnings Predictions
ATRenew Celebrates First Profit Amid Growing Trade-In Trend
Thanksgiving 2024 Travel: A Surge in Travelers Amid Challenges
Exploring Legal Paths for Chipotle Investors Facing Losses
Join the $JENNER Class Action and Protect Your Investment
Invesque Inc. Approves Major Financial Enhancements for Shareholders
Eli Lilly & Company Experiences Significant Stock Surge Today
Investigation Launched into ASP Isotopes Inc. and Its Practices
JOYY Inc. Updates Their 2024 Financial Performance Insights
China's Economic Forecast for 2025: Challenges and Opportunities
Inflation Data: Key Focus for US Stock Market Stability Ahead
ION Mining Launches Cutting-Edge Mobile App for Enthusiasts
New Australian Bill Seeks to Protect Children from Social Media
Investors Standing Against PACS Group's Alleged Misconduct
Important SEC Class Action Deadline for PACS Group Investors
Investors Eye Legal Actions as Xiao-I Faces Serious Allegations
Final Approval of Settlement Marks a New Era for Realtors
United Airlines Faces Challenges Due to Air Traffic Control Shortages
South Korea's Pension Fund Adjusts Dollar Holdings Amid Market Changes
NorthWest Copper Welcomes Paul Olmsted as New CEO
Investigation Launched as Acadia Healthcare Faces Claims
Investigation Launched for Match Group Investors Amid Significant Losses
Navigating Market Opportunities: Strategies for Investors in 2024
Hydreight Technologies Achieves Major Revenue Growth in Q3
Legal Investigations Alert: Shareholder Rights and Actions
NOVONIX Set to Shine at December Investor Engagements
Montfort Capital Reports Q3 Financials and Divestment Plan
Understanding Distribution Sources of Cohen & Steers Fund (RNP)
Exploring the Innovative Landscape of Cannabis with High Science
Understanding Cohen & Steers Total Return Realty Fund Distributions
Investment Insights from Cohen & Steers Opportunity Fund
Xerox Holdings Corporation: Investigating Investor Claims and Losses
Investigation Notice: Humacyte Investors Should Act Now
Fusion Fuel's Strategic Acquisition and Leadership Transition
Rivalry Corp. Announces Successful Non-Brokered Placement Raise
Cohen & Steers Infrastructure Fund Updates Distribution Insights
Growth Surge in Voice Evacuation Systems: A 1.1 Billion Leap
FIBRA Prologis Completes Tender Offer for Terrafina CBFIs
Understanding Distribution Sources for Cohen & Steers Realty Fund
Marpai Secures New Clients and Prepares for 2025 Growth
Lumina Gold's New Exploitation Contract Marks a Milestone
Goldman Sachs Shares Hedging Strategies for 2025 Market Risks
WattEV Advances EV Charging with New Rapid-Charging Standards
DIRTT Environmental Solutions Welcomes Holly Hess Groos
Mondee Faces Nasdaq Compliance Challenge Amid Leadership Changes
Teamsters Union Grows as FreshPoint Drivers Take a Stand
Challenges of Cannabis Legalization: Insights from Berlin's Justice Senator
TerrAscend Elevates Lynn Gefen to Chief People Officer Role
Maximus Inc Faces Uncertainty After Contract Cancellation